Professor
Hubert HondermarckProfile page
Professor
School of Biomedical Sciences and Pharmacy
- ProfessorSchool of Biomedical Sciences and Pharmacy
- 0249218830 (Work)
BIOGRAPHY
Hubert Hondermarck is Professor of Biomedical Sciences, specialised in Cancer Neuroscience. He obtained a PhD in neurobiochemistry at the University of Lille, France (1990) and was a post-doctoral researcher at the University of California Irvine (1990-1993). He created a research unit of the French Institute of Health and Medical Research dedicated to the study of growth factor signaling and functional proteomics in cancer. In 2011, he relocated to the University of Newcastle Australia, to start a new program investigating the role of the nervous system and neuromolecules in cancer initiation and progression. Hubert is currently the Head of the Cancer Neuroscience Laboratory in the School of Biomedical Science & Pharmacy, Head of the Cancer Detection & Therapy Program at the Hunter Medical Research Institute (HMRI), and stream leader of the Mark Hughes Foundation Centre for Brain Cancer Research.
Research Expertise: Cancer Neuroscience
The Hondermarck research group investigates the crosstalk between neurons and tumour cells in various malignancies, and its impact on cancer growth and metastasis. Recent evidence from our laboratory have introduced the new paradigm that the nervous system and neurons actually promote tumour initiation and progression in most human solid tumours including breast, thyroid, pancreatic, prostate and brain cancers. Denervation can suppress both the development of the primary tumour and the outburst of metastases by disrupting neurosignaling. The objective of this research is to identify the molecular mediators of the crosstalk between neurons and tumour cells, and develop them as innovative clinical biomarkers and therapeutic targets in oncology. The methodologies include the analysis of human tumour samples, cell cultures, in vivo models, proteomics and mass spectrometry analysis. We work in collaboration with neurobiologists, pathologists, clinicians and private companies to translate the results of our research into practical outcomes in oncology.
Full publication list: https://pubmed.ncbi.nlm.nih.gov/?term=hondermarck&sort=date
Representative recent publications:
Magnon C, Hondermarck H. The neural addiction of cancer. Nat Rev Cancer. 2023 May;23(5):317-334.
Jiang CC, Marsland M, Wang Y, Dowdell A, Eden E, Gao F, Faulkner S, Jobling P, Li X, Liu L, He Z, Hondermarck H. Tumor innervation is triggered by endoplasmic reticulum stress. Oncogene. 2022 Jan;41(4):586-599. doi: 10.1038/s41388-021-02108-6. Epub 2021 Nov 16. PMID: 34785777.
Li X, Liu H, Dun MD, Faulkner S, Liu X, Jiang CC, Hondermarck H. Proteome and secretome analysis of pancreatic cancer cells. Proteomics. 2022 Jul;22(13-14):e2100320.
Delahunt B, Steigler A, Atkinson C, Christie D, Duchesne G, Egevad L, Joseph D, Kenwright DN, Matthews J, Murray JD, Oldmeadow C, Samaratunga H, Spry NA, Thunders MC, Hondermarck H, Denham JW. Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. Pathology. 2022 Feb;54(1):49-54.
Monje M, Borniger JC, D'Silva NJ, Deneen B, Dirks PB, Fattahi F, Frenette PS, Garzia L, Gutmann DH, Hanahan D, Hervey-Jumper SL, Hondermarck H, Hurov JB, Kepecs A, Knox SM, Lloyd AC, Magnon C, Saloman JL, Segal RA, Sloan EK, Sun X, Taylor MD, Tracey KJ, Trotman LC, Tuveson DA, Wang TC, White RA, Winkler F. Roadmap for the Emerging Field of Cancer Neuroscience. Cell. 2020 Apr 16;181(2):219-222.
Faulkner S, Griffin N, Rowe CW, Jobling P, Lombard JM, Oliveira SM, Walker MM, Hondermarck H. Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma. FASEB Bioadv. 2020 Jun 30;2(7):398-408.
Gao F, Griffin N, Faulkner S, Li X, King SJ, Jobling P, Denham JW, Jiang CC, Hondermarck H. The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion. Am J Pathol. 2020 Sep;190(9):1931-1942.
Griffin N, Rowe CW, Gao F, Jobling P, Wills V, Walker MM, Faulkner S, Hondermarck H. Clinicopathological Significance of Nerves in Esophageal Cancer. Am J Pathol. 2020 Sep;190(9):1921-1930.
March B, Faulkner S, Jobling P, Steigler A, Blatt A, Denham J, Hondermarck H. Tumour innervation and neurosignalling in prostate cancer. Nat Rev Urol. 2020 Feb;17(2):119-130.
Delahunt B, Murray JD, Steigler A, Atkinson C, Christie D, Duchesne G, Egevad L, Joseph D, Matthews J, Oldmeadow C, Samaratunga H, Spry NA, Srigley JR, Hondermarck H, Denham JW. Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial. Histopathology. 2020 Apr 13.
Rowe CW, Dill T, Griffin N, Jobling P, Faulkner S, Paul JW, King S, Smith R, Hondermarck H. Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion. Sci Rep. 2020 Jan 30;10(1):1539.
Liu H, Li X, Dun MD, Faulkner S, Jiang CC, Hondermarck H. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and Can be Targeted to Inhibit Invasiveness in Pancreatic Cancer Cells. Proteomics. 2020 May;20(10):e1900331.
Faulkner S, Jobling P, March B, Jiang CC, Hondermarck H.Tumor Neurobiology and the War of Nerves in Cancer. Cancer Discov. 2019, 9(6):702-710.
Teaching
Biochemistry, Cancer Biology, Proteomics, Bioinformatics and functional genomics in both the Biomedical and Medical Programs.
Course coordinator for HUBS2209 (Cancer Biology and Oncology), HUBS3302 (Bioinformatic and Functional Genomics).
Research Expertise: Cancer Neuroscience
UNIVERSITY OF NEWCASTLE APPOINTMENTS
- ProfessorUniversity of Newcastle, School of Biomedical Sciences and Pharmacy, Australia12 Sep 2011 - present
DEGREES
- PhD (Life Sciences & Health)University of Lille - France19 Dec 1990
LANGUAGES
- FrenchCan read, write, speak, understand and peer review
- EnglishCan read, write, speak, understand and peer review
PROFILE TYPE
- Academic Staff
SUSTAINABLE DEVELOPMENT GOALS
- 3 Good Health and Well Being
- 4 Quality Education
SUPERVISION AVAILABILITY
- Available - Senior Supervisor
DISCIPLINE
- Medical Biochemistry